Pilleron J P, Durand J C, Lefranc J P, Pernin F, Robichez B
Can J Surg. 1981 Jul;24(4):368-73.
At the Institut Curie in Paris 452 invasive breast cancers (T1 and T2 less than 3 cm in diameter) were managed conservatively. The patients were treated by "conservative" surgery with or without axillary dissection. All received radiotherapy postoperatively. The 5-year survival without evidence of disease was 86% (249 cases). The survival at 10 years was 77% (93 cases). These statistics are comparable to those obtained by total mastectomy with axillary clearance. The local recurrence rate was 14.5%, most of these patients being "curable" by radical surgery. There was evidence of isolated axillary node metastases in only 2% of the patients. Radiotherapy is therefore effective in treating subclinical node invasion which was observed in 30% of axillary specimens. The cosmetic results were satisfactory in 80% and complications were rare. Follow-up of these patients is difficult and must be rigorous including clinical examination and mammography and, in case of doubt, cytology by aspiration or "Tru-cut" biopsy. The authors conclude that this conservative method, in addition to its cosmetic and emotional advantages, allows us to treat with as much security as radical surgery, the early cancers of the breast (T1 and T2 less than 3 cm in diameter), with no clinically suspicious node metastases.
在巴黎居里研究所,452例浸润性乳腺癌(直径小于3厘米的T1和T2期)采用了保守治疗。患者接受了有或无腋窝淋巴结清扫的“保守”手术治疗。所有患者术后均接受放疗。无疾病证据的5年生存率为86%(249例)。10年生存率为77%(93例)。这些统计数据与全乳切除术加腋窝清扫术的结果相当。局部复发率为14.5%,这些患者大多数可通过根治性手术“治愈”。仅2%的患者有孤立腋窝淋巴结转移的证据。因此,放疗对治疗亚临床淋巴结侵犯有效,在30%的腋窝标本中观察到这种情况。80%的患者美容效果令人满意,并发症很少。对这些患者的随访很困难,必须严格进行,包括临床检查和乳腺钼靶检查,如有疑问,需进行细针穿刺细胞学检查或“Tru-cut”活检。作者得出结论,这种保守方法除了具有美容和心理优势外,对于无临床可疑淋巴结转移的早期乳腺癌(直径小于3厘米的T1和T2期),能让我们以与根治性手术相同的安全性进行治疗。